BNP Paribas Financial Markets
TBIO

BNP Paribas Financial Markets’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

BNP Paribas Financial Markets’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$7 – 4262
2024
Q2 		$7 Buy
+2
New +$10 ﹤0.01% 4023

Other funds holding TBIO

CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

BNP Paribas Financial Markets's TBIO Position: Q3 2024 in Review

BNP Paribas Financial Markets sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2024, closing a stake of 2 shares — an estimated $7 sold.

BNP Paribas Financial Markets first reported a position in TBIO in Q2 2024 and held it in 1 quarter. The position peaked at $7 in Q2 2024. 1 fund tracked by Wall St. Rank holds TBIO as of Q3 2024.

  • BNP Paribas Financial Markets reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2 Telesis Bio, Inc. Common Stock shares in Q3 2024, an estimated $7.
  • BNP Paribas Financial Markets first reported a position in Telesis Bio, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Telesis Bio, Inc. Common Stock position peaked at $7 in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2024.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2024, filed 13 Nov 2024.